Bicycle Therapeutics Plc
Bicycle Therapeutics develops Bicycle molecules, synthetic constrained peptides for drug conjugates targeting cancer antigens.
8-KAug 20Latest SEC filing, period to Aug 18
Aug 20Latest story
August 2026
July 2026
Sign inSign inBicycle Therapeutics develops Bicycle molecules, synthetic constrained peptides for drug conjugates targeting cancer antigens.